Process Industries · Chemicals: Specialty · NSE: INDIAGLYCO · data 2026-10-09
India Glycols Limited
Health check: Strong (8.3/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹329.6
Market cap
₹2,397 cr
P/E
6.8
P/B
—
ROE
11.3%
ROCE
12.0%
Debt / equity
0.58
Dividend yield
3.50%
1-year return
78.0%
52-week high
₹399
52-week low
₹163.68
Operating margin
11.8%
Growth
| Revenue (last 12 months) | ₹4,301 cr |
| Net profit (last 12 months) | ₹316 cr |
| Sales growth, 3 years (yearly) | 16.8% |
| Profit growth, 3 years (yearly) | 32.8% |
Chart patterns
- Double top — breakdown (key level ₹1,044)
Similar companies
Apcotex Industries Ltd (APCOTEXIND) · NOCIL Limited (NOCIL) · JG Chemicals Limited (JGCHEM) · Rossari Biotech Ltd (ROSSARI) · Fischer Medical Ventures Ltd (FISCHER)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open INDIAGLYCO in NSE Scanner →